252 related articles for article (PubMed ID: 36727583)
1. Self-assembled nanomaterials for ferroptosis-based cancer theranostics.
Ma G; Wang K; Pang X; Xu S; Gao Y; Liang Y; Yang J; Zhang X; Sun X; Dong J
Biomater Sci; 2023 Mar; 11(6):1962-1980. PubMed ID: 36727583
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics.
Zhang X; Ma Y; Wan J; Yuan J; Wang D; Wang W; Sun X; Meng Q
Front Chem; 2021; 9():768248. PubMed ID: 34869212
[TBL] [Abstract][Full Text] [Related]
3. The potential application of nanomaterials for ferroptosis-based cancer therapy.
Li Y; Wei X; Tao F; Deng C; Lv C; Chen C; Cheng Y
Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34038885
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
[TBL] [Abstract][Full Text] [Related]
5. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications.
Luo L; Wang H; Tian W; Li X; Zhu Z; Huang R; Luo H
Theranostics; 2021; 11(20):9937-9952. PubMed ID: 34815796
[TBL] [Abstract][Full Text] [Related]
6. Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies.
Dhas N; Kudarha R; Tiwari R; Tiwari G; Garg N; Kumar P; Kulkarni S; Kulkarni J; Soman S; Hegde AR; Patel J; Garkal A; Sami A; Datta D; Colaco V; Mehta T; Vora L; Mutalik S
Life Sci; 2024 Jun; 346():122629. PubMed ID: 38631667
[TBL] [Abstract][Full Text] [Related]
7. Bioactive inorganic nanomaterials for cancer theranostics.
Pei Z; Lei H; Cheng L
Chem Soc Rev; 2023 Mar; 52(6):2031-2081. PubMed ID: 36633202
[TBL] [Abstract][Full Text] [Related]
8. Deeper insight into ferroptosis: association with Alzheimer's, Parkinson's disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis.
Yadav VK; Choudhary N; Gacem A; Verma RK; Abul Hasan M; Tarique Imam M; Almalki ZS; Yadav KK; Park HK; Ghosh T; Kumar P; Patel A; Kalasariya H; Jeon BH; Ali AlMubarak H
Redox Rep; 2023 Dec; 28(1):2269331. PubMed ID: 38010378
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis in cancer therapeutics: a materials chemistry perspective.
Guan Q; Zhou LL; Dong YB
J Mater Chem B; 2021 Nov; 9(43):8906-8936. PubMed ID: 34505861
[TBL] [Abstract][Full Text] [Related]
10. Ionizing Radiation-Induced Ferroptosis Based on Nanomaterials.
Zhang S; Zhang J; Fan X; Liu H; Zhu M; Yang M; Zhang X; Zhang H; Yu F
Int J Nanomedicine; 2022; 17():3497-3507. PubMed ID: 35966149
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer.
Huang M; Teng Q; Cao F; Huang J; Pang J
Biomater Sci; 2024 Mar; 12(7):1617-1629. PubMed ID: 38379396
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in biomaterials-driven ferroptosis for cancer therapy.
Xiao N; Xiong S; Zhou Z; Zhong M; Bai H; Li Q; Tang Y; Xie J
Biomater Sci; 2024 Jan; 12(2):288-307. PubMed ID: 38189655
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-Inducing Nanomedicine for Cancer Therapy.
Wang Y; Liu T; Li X; Sheng H; Ma X; Hao L
Front Pharmacol; 2021; 12():735965. PubMed ID: 34987385
[TBL] [Abstract][Full Text] [Related]
14. Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics.
Wang S; Li F; Qiao R; Hu X; Liao H; Chen L; Wu J; Wu H; Zhao M; Liu J; Chen R; Ma X; Kim D; Sun J; Davis TP; Chen C; Tian J; Hyeon T; Ling D
ACS Nano; 2018 Dec; 12(12):12380-12392. PubMed ID: 30495919
[TBL] [Abstract][Full Text] [Related]
15. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicines for Renal Management: From Imaging to Treatment.
Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
[TBL] [Abstract][Full Text] [Related]
17. Engineering iron-based nanomaterials for breast cancer therapy associated with ferroptosis.
Wei R; Fu G; Li Z; Liu Y; Xue M
Nanomedicine (Lond); 2024 Jan; ():. PubMed ID: 38293902
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment.
Farzipour S; Zefrei FJ; Bahadorikhalili S; Alvandi M; Salari A; Shaghaghi Z
Anticancer Agents Med Chem; 2024; 24(8):571-589. PubMed ID: 38275050
[TBL] [Abstract][Full Text] [Related]
19. Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook.
Sepand MR; Ranjbar S; Kempson IM; Akbariani M; Muganda WCA; Müller M; Ghahremani MH; Raoufi M
Nanomedicine; 2020 Oct; 29():102243. PubMed ID: 32623018
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer.
Shi TM; Chen XF; Ti H
J Med Chem; 2024 Feb; 67(4):2238-2263. PubMed ID: 38306267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
